AI-first telehealth marketplace for weight loss and obesity care
Mochi Health runs a telehealth marketplace linking patients, providers and pharmacies, with obesity care as its core specialty. The stack pairs React Native/Expo apps and Apple HealthKit with a heavy paid-acquisition layer (Meta, Snapchat, Pinterest, The Trade Desk, DV360, AppsFlyer) and Braze/Iterable/Customer.io lifecycle tools. Senior-skewed engineering and design hiring targets provider charting, medical intake engines and clinical state machines.
Mochi Health is a San Francisco-based telehealth company founded in 2022, focused on weight loss and obesity treatment. Its platform connects patients with providers and pharmacies, letting patients select their own care while providers work through in-house clinical tooling. The company employs 51–200 people, is privately held, and hires in the United States. Its product spans patient-facing mobile and web applications, intake flows, provider dashboards and subscription billing, built on AWS and Kubernetes.
Mochi Health uses React, React Native, Expo, TypeScript and Python on AWS and Kubernetes, plus Apple HealthKit, Looker, Streamlit, Braze, Iterable, Customer.io and Talkdesk.
Job posts point to provider charting dashboards, multi-step medical intake engines, obesity-specific protocols, an AI-driven care marketplace, transparent pharmacy pricing and subscription billing infrastructure.
Yes. Engineering is the largest hiring area, mostly at senior level, alongside design and healthcare roles, all based in the United States with steady hiring velocity.
Other companies in the same industry, closest in size
Mochi Health's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.